نتائج البحث 241-250 من 5301 لعملية البحث عن Substance+dependence
Accessed March 14, 2023. Mixing medications and dietary supplements can endanger your health. U.S. Food and Drug Administration. https://www.fda.gov/consumers/ ...
The purpose of this study is to establish an opioid and multiple addiction (OMA) biobank that creates a comprehensive standard patient phenotype using ...
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...
Jacksonville, Fla. This study is researching an experimental drug called ubamatamab, also referred to as "study drug". The study is focused on patients who ...
Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma.
Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. A Colon Bank for Early ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
(افتح الدراسات فقط). غربل قائمة الدراسات هذه بالموقع والحالة وغيرها. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment ...
A bimonthly publication for physicians that discusses trends and advances in hematology and oncology at Mayo Clinic. View newsletters. Cardiovascular Diseases ...
The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.